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Small nucleolar RNAs (snoRNAs)2 are a class of non-coding
RNAs that range from 60 to 250 nucleotides in length. In mammalian cells, the majority of snoRNAs are encoded within
introns and processed from lariats during splicing. snoRNAs
assemble into small nucleolar ribonucleoprotein (snoRNP)
complexes with RNA-modifying enzymes and traffic to the
nucleolus, where their canonical function is to guide sitespecific nucleotide modifications of rRNA and snRNA. Two
classes of snoRNAs are defined by conserved sequence motifs,
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associated proteins, and snoRNA-directed modifications. Box
C/D snoRNAs complex with fibrillarin and guide 2⬘-O-methylation of targets, whereas box H/ACA snoRNAs complex with
dyskerin and guide pseudouridylation of targets (1–3). In addition to these canonical roles, there is growing evidence for
non-canonical molecular functions of snoRNAs, including
miRNA-like post-transcriptional regulation, pseudouridylation of mRNA targets, modification of pre-mRNAs to direct
splicing, and regulation of RNA editing (4 –7).
Our laboratory previously identified that box C/D snoRNAs
encoded within the introns of the ribosomal protein L13a
(Rpl13a) gene are critical mediators of the cellular response to
palmitate-induced lipotoxic stress and play a physiological role
in tissue responses to oxidative stress (8 –10). Although Rpl13a
snoRNAs localize primarily in the nucleus, these and other
snoRNAs are readily detected in the cytoplasm under homeostatic conditions (11, 12), and they accumulate outside the
nucleus during lipotoxic conditions, oxidative stress, and serum
starvation (8, 10, 13). In addition to the pathways for nuclear
export of snoRNAs implicated by these findings, studies in
Xenopus oocytes provide evidence for an endogenous pathway
that transports snoRNAs from the cytoplasm to the nucleus
following microinjection (14). Moreover, U8 snoRNA associates with the import factor snurportin 1 in mammalian cells,
and knockdown of this transport adaptor is associated with
increased cytoplasmic U8 (11). Whether snurportin 1 serves a
broader role in transport of the overall class of snoRNAs and
whether other transport proteins function to regulate the distribution of snoRNAs between the nucleus and cytoplasm is not
known.
We identified nuclear export factor 3 (NXF3) through an
shRNA loss-of-function genetic screen in human umbilical vein
endothelial cells to identify genes required for the cytotoxic
response to metabolic stress. Based on sequence similarity,
NXF3 is considered to be a member of a nuclear RNA export
factor family that includes the known mRNA exporter, nuclear
export factor 1 (NXF1). Like other family members, NXF3 shuttles between the nucleus and cytoplasm and can associate with
and transport poly(A)⫹ RNA (15). Given that our genetic
screens implicated both snoRNAs and NXF3 in lipotoxic
response pathways, we hypothesized that NXF3 may also serve
as a transporter for snoRNAs. Herein, we demonstrate that
NXF3 regulates distribution of the Rpl13a snoRNAs between
the nucleus and the cytosol under homeostatic conditions.
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Small nucleolar RNAs (snoRNAs) guide chemical modifications of ribosomal and small nuclear RNAs, functions that are
carried out in the nucleus. Although most snoRNAs reside in the
nucleolus, a growing body of evidence indicates that snoRNAs
are also present in the cytoplasm and that snoRNAs move
between the nucleus and cytoplasm by a mechanism that is regulated by lipotoxic and oxidative stress. Here, in a genome-wide
shRNA-based screen, we identified nuclear export factor 3
(NXF3) as a transporter that alters the nucleocytoplasmic distribution of box C/D snoRNAs from the ribosomal protein L13a
(Rpl13a) locus. Using RNA-sequencing analysis, we show that
NXF3 associates not only with Rpl13a snoRNAs, but also with a
broad range of box C/D and box H/ACA snoRNAs. Under
homeostatic conditions, gain- or loss-of-function of NXF3, but
not related family member NXF1, decreases or increases cytosolic Rpl13a snoRNAs, respectively. Furthermore, treatment
with the adenylyl cyclase activator forskolin diminishes cytosolic localization of the Rpl13a snoRNAs through a mechanism
that is dependent on NXF3 but not NXF1. Our results provide
evidence of a new role for NXF3 in regulating the distribution of
snoRNAs between the nuclear and cytoplasmic compartments.

NXF3 regulates localization of snoRNAs
NXF3 associates with a broad array of box C/D and box H/ACA
snoRNAs, including the Rpl13a snoRNAs. Treatment of cells
with the adenylyl cyclase activator forskolin decreases cytosolic
snoRNAs through a mechanism that is dependent on NXF3
expression. Our data provide new insights into the molecular
regulation of snoRNA localization.

NXF3 knockdown endothelial cells have aberrant Rpl13a
snoRNA localization
Although NXF3 can associate with mRNAs, other potential
cargo such as non-coding RNAs has not been investigated (16).
Given the important role of Rpl13a snoRNAs U32a, U33,
U34, and U35a in lipotoxic and oxidative stress-induced cell
death and the observation that these snoRNAs accumulate in
the cytoplasm under metabolic stress conditions (8, 10), we
hypothesized that NXF3 knockdown might affect localization
of snoRNAs. We assessed Rpl13a snoRNA localization in cytosolic fractions of control- and NXF3-shRNA-transduced cells
by isolating cytosolic and non-cytosolic fractions using digitonin extraction. Under normal homeostatic growth conditions,
levels of cytosolic Rpl13a snoRNAs in NXF3 shRNA-transduced cells were significantly increased compared with control
shRNA-transduced cells, even though total cellular abundance
for these snoRNAs was unchanged (Fig. 2A). Western blottings
demonstrated that both nuclear (nucleophosmin) and cytosolic
(HSP90, ␣-tubulin) markers segregated as expected in both

Figure 1. Knockdown of NXF3 protects against lipotoxic cell death in
endothelial cells. HUVECs were transduced with non-targeting (ctrl) or
NXF3-targeting shRNA. A, quantification of ER stress markers (CHOP and ATF4)
by RT-qPCR relative to Rplp0 (relative units, RU) following 4 h of incubation in
media containing 500 M palmitate. n ⫽ 3 independent experiments. B, viability following 48 h of incubation in media containing 500 M palmitate. n ⫽
4. C, RT-qPCR quantification of NXF3 mRNA relative to Rplp0. n ⫽ 3. D, representative Western blot analysis of NXF3 and HSP90 expression (top panels)
and corresponding Ponceau-stained gel (bottom panel). Graphs report quantification of NXF3 expression relative to HSP90 or total protein from n ⫽ 3.
Means ⫾ S.D. *, p ⬍ 0.05; **, p ⬍ 0.01 for NXF3 knockdown versus control.

control and NXF3 shRNA-transduced cells (Fig. 2B). Consistent with prior observations in other cell types that oxidative
stress stimulates cytosolic accumulation of Rpl13a snoRNAs (8,
17), U32a, U33, and U34 snoRNAs accumulate in the cytoplasm
of control shRNA-transduced HUVECs in response to treatment with hydrogen peroxide (Fig. 2C). Hydrogen peroxide had
no detectable effect on localization of U35a, which is the least
abundant of the Rpl13a snoRNAs and shows less robust cytosolic accumulation in response to other metabolic stress inducers (8). In NXF3 shRNA-transduced cells, hydrogen peroxide
did not cause further increase in the cytoplasmic levels of
Rpl13a snoRNAs. Elevated cytoplasmic levels of the snoRNAs
under homeostatic conditions in NXF3 shRNA-transduced
cells are unlikely to be the result of increased basal oxidative
stress, because intracellular hydrogen peroxide levels as assessed
by dihydroethidium staining were unchanged compared with
control cells (Fig. 2D). Nucleophosmin staining showed preservation of discrete nucleolar foci in NXF3 shRNA-transduced
cells, in contrast to the diffuse nucleophosmin staining characteristic of nucleolar stress in hydrogen peroxide-treated cells
(Fig. 2E), indicating that NXF3 knockdown does not cause
nucleolar stress (18). Our findings that loss-of-function of
NXF3 perturbs Rpl13a snoRNA subcellular localization indicates that NXF3 functions under homeostatic conditions to
maintain the distribution of these non-coding RNAs between
the nucleus and cytoplasm. Although NXF3 has been proposed
J. Biol. Chem. (2017) 292(49) 20228 –20239
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Results
Knockdown of NXF3 protects against lipotoxic cell death in
endothelial cells
To identify genes critical for the cell death response to lipotoxicity, we performed a genome-wide loss-of-function shRNA
screen in immortalized human umbilical vein endothelial cells
(HUVECs), which are sensitive to lipotoxicity. Cells were transduced with seven pools of lentivirus, each containing ⬃10,000
unique shRNAs targeting expressed human genes and a puromycin selectable marker. As a control, cells were transduced in
parallel with a non-silencing shRNA virus that has no homology to known mammalian genes. HUVECs that survived puromycin selection were then treated for 48 h in media supplemented with pathophysiological levels of palmitic acid to model
lipotoxic conditions. Compared with cells transduced with the
non-silencing control shRNA, cells transduced with an shRNA
targeting NXF3 demonstrated less induction of markers of
endoplasmic reticulum stress, an early feature of the lipotoxic
response (Fig. 1A). Furthermore, cells with the NXF3-targeting
shRNA had improved viability under lipotoxic conditions (Fig.
1B). The shRNA targeting NXF3 led to a 72% decrease in NXF3
mRNA levels (Fig. 1C) and a 31% decrease in NXF3 protein
expression (Fig. 1D), consistent with knockdown of its gene
target in these lipotoxicity-sensitive human cells. NXF3 is a
member of the NXF family that includes the general mRNA
export receptor, NXF1. Our shRNA library included shRNAs
that target NXF1, but cells transduced with NXF1-targeting
shRNA or shRNA targeting other known RNA transporters did
not survive the palmitate selection. Together these observations implicate a critical role for NXF3, but not NXF1, in the
lipotoxic response pathway.

NXF3 regulates localization of snoRNAs

as an mRNA export factor, accumulation of Rpl13a snoRNAs in
the cytosol in the setting of NXF3 knockdown implicates an
additional role for this protein in nuclear import of these small
non-coding RNAs.
NXF3 and NXF1 associate with snoRNAs
Because NXF3 is a member of a nuclear RNA transporter
family, and genetic manipulation of NXF3 impacted Rpl13a
snoRNA localization, we hypothesized that NXF3 may serve as
a snoRNA transporter. To further elucidate the effects of NXF3
on snoRNA localization, we used NIH3T3 murine fibroblasts
and H9c2 rat cardiomyoblasts, cell types that are also sensitive
to lipotoxocity but grow more rapidly in cell culture and transfect with greater efficiency than HUVECs (8, 10, 19). To test
whether NXF3 physically interacts with the Rpl13a snoRNAs,
we transiently transfected NIH3T3 fibroblasts with NXF3-GFP
or GFP alone as a negative control. We also transfected cells
with NXF1-GFP, another NXF family member with related
domain structure (Fig. 3A). We performed immunoprecipitations using a GFP antibody or non-immune IgG as a control.
Antibody directed against GFP efficiently and specifically
pulled down NXF3-GFP, NXF1-GFP, or GFP, whereas no
NXF3-GFP, NXF1-GFP, or GFP was recovered in control
immunoprecipitations (Fig. 3B). Real-time PCR quantification
revealed a 9 –12-fold increase in Rpl13a snoRNA association
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with immunoprecipitated NXF3-GFP compared with immunoprecipitated GFP (Fig. 3C). Unexpectedly, the Rpl13a snoRNAs also associated with NXF1-GFP. These data indicate that
under mild detergent conditions chosen to preserve RNA–
protein interactions, both NXF3-GFP and NXF1-GFP associate
with the Rpl13a snoRNAs. This may reflect an ability of these
transporters to bind a broad range of RNA species.
We used RNA-sequencing to determine whether NXF3 associates only with Rpl13a snoRNAs or with snoRNAs more
broadly. We collected RNA from cell lysates before immunoprecipitation (input) and RNA from immunoprecipitates (pulldown) of NIH3T3 murine fibroblasts transfected with NXF3GFP. Because most snoRNAs lack poly(A) tails and do not
efficiently prime with random hexamers, they are not well-represented in libraries prepared using approaches suitable for
larger RNAs (20). To achieve broad coverage of snoRNAs from
both input and pulldown samples, we size-selected RNAs from
30 to 375 nucleotides, a range that would exclude most miRNAs
and include most snoRNAs. Libraries were prepared using an
Illumina small RNA library preparation kit, sequenced, and
aligned to mm9 Refseq Transcripts. We focused our analyses
on the non-rRNA sequences, which accounted on average for
55% reads in both input and pulldown samples (Table 1).
Greater than 98% of non-rRNA reads in the input and pulldown
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Figure 2. NXF3 knockdown alters Rpl13a snoRNA localization under basal growth conditions in endothelial cells. HUVECs were transduced with control
(ctrl) or NXF3-targeting shRNA. A, RT-qPCR quantification of Rpl13a snoRNAs (relative to Rplp0) in cytosolic (left graph) or total extracts (right graph). n ⫽ 4. B,
representative Western blot analysis of cytosolic and non-cytosolic fractions for cytosolic (HSP90; ␣-tubulin, TUB) and nuclear (nucleophosmin, NPM) markers.
C, cells were untreated or treated with 1 mM H2O2 for 4 h. RT-qPCR quantification of Rpl13a snoRNAs in cytoplasm relative to Rplp0 and normalized to levels in
untreated control shRNA-transduced cells. n ⫽ 3. D, quantification of superoxide in untreated control and NXF3-knockdown cells by DHE staining. n ⫽ 3
independent experiments, each sample containing 104 cells. E, representative immunofluorescence staining for NPM in untreated and H2O2-treated cells.
Nuclei stained with DAPI. Scale bar, 50 M. Means ⫾ S.D. *, p ⬍ 0.05 for NXF3 versus control shRNA-transduced cells; #, p ⬍ 0.05 for H2O2-treated versus
-untreated; ns, non-significant.

NXF3 regulates localization of snoRNAs

Table 1
Quality of RNA sequencing data
Total
reads
Input 1
Input 2
Input 3
Pulldown 1
Pulldown 2
Pulldown 3

12622611
8494636
15845764
3321562
19470767
13412207

Table 2
Distribution of non-ribosomal RNA reads

Avg.
quality

%
G/C

Total
aligned

36.56
36.53
36.57
36.63
36.55
36.55

42.81
43.23
42.99
43.40
42.52
42.45

6914155
3561964
7717165
1498556
12639529
6330452

%
aligned

%
rRNA

54.78
41.93
48.70
45.12
64.92
47.20

49.32
36.13
42.95
38.85
59.51
43.59

samples aligned to snoRNAs, as expected (Table 2). In addition
to the Rpl13a snoRNAs, NXF3 pulldown recovered many other
snoRNAs (Table 3), most of which belonged to the box C/D
class of snoRNAs, known to be most abundant (21–23).
Approximately 6% of reads in both input and pulldown aligned
to box H/ACA snoRNAs. Because of the methods required to
capture snoRNA sequences in library preparation, it was not
possible to determine whether NXF3 specifically enriches for

NS means not significant.
RNA
C/D snoRNA
H/ACA snoRNA
lncRNA
miRNA
mRNA
Other

Input

Pull down

%

%

92.45 ⫾ 0.93
6.26 ⫾ 0.79
0.24 ⫾ 0.04
0.27 ⫾ 0.02
0.76 ⫾ 0.09
0.02 ⫾ 0.00

91.92 ⫾ 1.69
6.98 ⫾ 1.50
0.33 ⫾ 0.08
0.19 ⫾ 0.07
0.59 ⫾ 0.13
0.00 ⫾ 0.00

Significance
NS
NS
NS
NS
NS
NS

snoRNAs over other classes of RNAs. Nonetheless, the lack of
significant enrichment of specific snoRNA species in pulldown
relative to input snoRNAs indicates that NXF3 broadly associates with this class of small RNAs and does not have specificity
for the Rpl13a snoRNAs or other particular species (Table 3).
To validate association of NXF3 with additional box C/D and
box H/ACA snoRNAs and to test whether NXF1 also interacted
J. Biol. Chem. (2017) 292(49) 20228 –20239
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Figure 3. snoRNAs associate with NXF proteins. A, domain structures of NXF1 and NXF3 showing RNA-binding domain (RBD), four leucine-rich repeat
domain (4⫻ LRR), sequence with similarity to nuclear transport factor 2 (NTF2-like (p15 binding)), ubiquitin-associated-like domain (UBA), nuclear localizing
sequence (NLS), nuclear export sequence (NES), and CRM1-binding region. B and C, NIH3T3 fibroblasts were transfected with control plasmid (GFP) or plasmid
encoding NXF3-GFP or NXF1-GFP. Immunoprecipitation with ␣-GFP or rabbit IgG (control) was analyzed by Western blot analysis using ␣-GFP (B). Coimmunoprecipitating RNA was quantified by RT-qPCR for Rpl13a snoRNAs and selected box C/D and box H/ACA snoRNAs. Graphs (C) report enrichment in
NXF3-GFP- or NXF1-GFP-transfected cells over GFP-transfected cells. Means ⫾ S.D. for n ⫽ 3. *, p ⬍ 0.05 for NXF3-GFP- or NXF1-GFP-transfected versus
GFP-transfected.

NXF3 regulates localization of snoRNAs
Table 3
Most abundant immunoprecipitating snoRNAs
FDR means false discovery rate, and NS means not significant.
Gene ID

LS mean (input)

Enrichment
(pull down/input)

FDR

p value

Significance

421533.33
299548.00
229492.67
208143.67
144321.67
120987.00
97189.00
76795.67
70041.33
56763.00
50187.00
29898.00
26526.00
23828.33
23639.33
18182.33
14650.00
11345.33
10821.67
9882.33
8164.00
5050.33
4508.67
4491.33
3567.00
2406.67
2392.67
2302.00
2044.33
1497.33
1280.00
1268.67
980.33
963.33
746.67
650.00
647.33
505.67
478.00
317.33
297.33
271.51
220.00
198.00
189.33
180.00
163.33

422930.00
218320.33
218334.00
156536.67
150285.33
114743.00
82084.33
86895.67
78718.67
51011.67
32887.00
36448.00
17509.67
20331.67
36071.67
14849.67
11996.67
10193.33
9770.33
7793.67
8715.67
7777.33
5383.67
3655.33
2764.67
3323.33
2097.33
2378.67
862.67
881.00
1128.67
1322.00
984.00
1123.33
466.00
674.67
366.67
525.67
545.67
388.00
158.00
742.24
144.67
134.00
340.00
212.67
144.00

1.00
1.37
1.05
1.33
0.96
1.05
1.18
0.88
0.89
1.11
1.53
0.82
1.51
1.17
0.66
1.22
1.22
1.11
1.11
1.27
0.94
0.65
0.84
1.23
1.29
0.72
1.14
0.97
2.37
1.7
1.13
0.96
1.00
0.86
1.60
0.96
1.77
0.96
0.88
0.82
1.88
0.37
1.52
1.48
0.56
0.85
1.13

1.00
0.99
0.99
0.99
1.00
0.99
0.99
0.99
0.99
0.99
1.00
1.00
0.99
0.99
1.00
0.99
0.99
0.99
1.00
1.00
1.00
1.00
0.99
1.00
1.00
0.99
1.00
1.00
1.00
1.00
1.00
1.00
1.00
0.99
1.00
0.99
0.99
0.99
1.00
0.99
1.00
1.00
0.99
1.00
1.00
1.00
1.00

0.84
0.87
0.56
0.90
0.64
0.87
0.77
0.57
0.64
0.90
0.91
0.53
0.99
0.74
0.62
0.79
0.77
0.61
0.61
0.84
0.49
0.43
0.81
0.97
0.98
0.50
0.76
0.42
0.34
0.87
0.99
0.45
0.47
0.74
0.88
0.61
0.98
0.81
0.69
0.87
0.62
0.07
0.93
0.78
0.24
0.42
0.75

NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS

with these snoRNAs, we transfected NIH3T3 fibroblasts
with NXF3-GFP, NXF1-GFP, or GFP as control, immunoprecipitated with antibody to GFP, and we performed RTqPCR on recovered RNA for abundant snoRNAs for which
stem-loop primers were successfully designed. Each of the
snoRNAs tested showed enrichment in NXF3-GFP pulldown over GFP pulldown (Fig. 3B). Most of these snoRNAs
also associated with NXF1-GFP. Together, our data indicate
that both NXF3 and NXF1 are capable of associating with a
broad range of snoRNAs.
Knockdown and overexpression of NXF3 alters cytosolic
Rpl13a snoRNAs in cardiomyoblasts
Although both NXF3 and NXF1 can associate with snoRNAs, only NXF3 conferred enhanced viability in our lipotoxicity screen in HUVECs. To compare the effects of NXF3 and
NXF1 on snoRNA localization, we transfected H9c2 rat cardiomyoblasts with siRNAs to knock down either NXF3 or
NXF1. Compared with control non-targeting siRNA, two independent siRNAs directed against NXF3 led to a 93 and 84%

20232 J. Biol. Chem. (2017) 292(49) 20228 –20239

decrease in NXF3 mRNA levels, respectively, in cardiomyoblasts. NXF3 siRNAs were specific and did not significantly
change levels of family member NXF1 (Fig. 4A, left graph). We
found that commercially available antibodies directed against
rodent NXF3 are not specific for this family member (data not
shown), and our attempts to generate a specific antibody that
recognizes the rat or murine protein were unsuccessful, thus
precluding confirmation of the extent of knockdown of the
endogenous NXF3 protein. Nonetheless, knockdown of NXF3
mRNA led to a 50 –100% increase in cytosolic levels of the
Rpl13a snoRNAs (Fig. 4A, right graph) without perturbing efficiency of fractionation (Fig. 4B). In contrast, siRNA knockdown
of NXF1 had no effect on cytosolic levels of Rpl13a snoRNAs
(Fig. 4, C and D). Thus, accumulation of Rpl13a snoRNAs in the
cytosol can result from either acute or chronic knockdown of
NXF3. This effect is consistent across different cell types (endothelial cells and cardiomyoblasts) and is not observed with
knockdown of NXF1.
Our data are consistent with a model in which NXF3 function is required to maintain low cytoplasmic levels of the

Downloaded from http://www.jbc.org/ at Washington University on January 5, 2018

Snord55
Snord44
Z23
Snord24
Snord2
Snora48
Snord45
Z19
Z15
Snord14e
Snord4a
Snord96a
Snord45c
Snord74
Snord32a
Snord14d
Snord14c
Snord73
Snord34
Snord95
Snord1b
Snord35a
Snord113
Snord82
Snord104
DQ267100
Snord100
Snord1c
Snord12
Snord33
Snord15b
Snord123
Rnu73b
DQ267102
Snord92
Snord37
AF357426
AF357425
Snord15a
AF357355
Snord110
Snora24
Z21
Gm24148
Snord22
Snora52
Snora16a

LS mean
(pull down)

NXF3 regulates localization of snoRNAs

Rpl13a snoRNAs. To test whether NXF3 promotes movement
of snoRNAs between the cytosol and nucleus, we overexpressed
murine NXF3 by transiently transfecting NIH3T3 murine
fibroblasts with a GFP-tagged NXF3 construct (NXF3-GFP),
a GFP-tagged NXF1 construct (NXF1-GFP), or a plasmid
expressing GFP alone as control. We consistently observed
more efficient transfection with GFP (76%) compared with
NXF3-GFP (46%) or NXF1-GFP (40%), suggesting that endogenous mechanisms serve to restrict the overall expression of
NXF3 and NXF1 (Fig. 5A). Nonetheless, compared with expression of GFP alone, expression of NXF3-GFP decreased cytosolic levels of the Rpl13a snoRNAs by 16 –34%, whereas NXF1GFP did not significantly change cytosolic levels (Fig. 5, B and
C). Together with findings from knockdown of NXF3, our data
suggest a model in which NXF3 specifically promotes movement of snoRNAs from the cytoplasm to the nucleus and determines the distribution of the snoRNAs between these cellular
compartments.
Regulation of snoRNA trafficking and association with NXF3
Nucleocytoplasmic transport can serve as a point of regulation of subcellular localization for proteins as well as RNAs (24).
Cyclic AMP is a potent regulator of protein trafficking, but it is
not known whether this second messenger impacts NXF3 or
snoRNA localization. We found that treatment of fibroblasts
for 1 h with forskolin (FSK), an adenylyl cyclase activator, which
increases cyclic AMP levels, significantly decreased cytosolic
Rpl13a snoRNA levels compared with DMSO-treated controls
(Fig. 6, A and B). To test whether FSK affects NXF3 localization
or its association with snoRNAs, we transfected fibroblasts with
a plasmid for expression of NXF3-GFP or NXF1-GFP. Similar
to our findings with untransfected cells, cells overexpressing

NXF3-GFP or NXF1-GFP had decreased cytosolic snoRNA
abundance following 1 h of treatment with FSK (Fig. 6, C–F).
Moreover, FSK increased association of NXF3-GFP with the
Rpl13a snoRNAs (Fig. 7A). Concomitantly, immunofluorescence microscopy revealed increased nuclear localization of
NXF3-GFP (Fig. 7B). By contrast FSK did not affect snoRNA
association with NXF1-GFP or the cellular distribution of
NXF1-GFP, which is predominantly nuclear (Fig. 7, C and D).
Together, these observations are consistent with a model of
NXF3-mediated trafficking of snoRNAs from the nucleus to the
cytoplasm that is regulated by FSK. Moreover, these findings
lend further specificity to the function of NXF3 in snoRNA
trafficking.
To establish whether the FSK-induced changes in localization of Rpl13a snoRNAs are dependent on NXF3, cardiomyoblasts were transiently transfected with siRNA to knock down
NXF3 (Fig. 8A) and then treated with FSK. Although FSK
decreased cytosolic Rpl13a snoRNAs as expected in control
siRNA-transfected cells, this effect was abrogated when NXF3
was knocked down with either of two independent siRNAs (Fig.
8B). In contrast, NXF1 siRNA knockdown had no effect on the
FSK-snoRNA phenotype (Fig. 8B). Taken together, our data are
most consistent with a model in which NXF3 plays a critical
role in return of snoRNAs from the cytoplasm to the nucleus, a
pathway that can be activated by FSK.

Discussion
The endogenous substrates for NXF3, a member of a family
of RNA transport proteins, are not well-characterized. Additionally, relatively little is known regarding the regulation of
distribution of snoRNAs between the nucleus and cytoplasm.
Herein, we demonstrate that gain- and loss-of-function of
J. Biol. Chem. (2017) 292(49) 20228 –20239
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Figure 4. Knockdown of NXF3, but not NXF1, alters Rpl13a snoRNA localization. H9c2 cardiomyoblasts were transfected with scrambled siRNA (ctrl) or two
independent siRNAs targeting NXF3 (A and B) or siRNAs targeting NXF1 (C and D). RT-qPCR quantification of NXF3 and NXF1 in total RNA (A and C, left graphs)
and Rpl13a snoRNAs in cytosolic RNA (A and C, right graphs) for n ⫽ 3. Representative Western blot analysis (B and D) of cytosolic and non-cytosolic fractions for
cytosolic (HSP90 and TUB) and nuclear (NPM) markers as controls for A and C, respectively. Means ⫾ S.D. *, p ⬍ 0.05 for NXF3 or NXF1 knockdown versus control.
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Figure 6. Forskolin decreases Rpl13a snoRNAs in cytoplasm. A, C, and E,
untransfected NIH3T3 fibroblasts (A), cells transfected with NXF3-GFP (C), and
cells transfected with NXF1-GFP (E) were treated with 10 M FSK or vehicle
(DMSO) for 1 h. Quantification of cytosolic snoRNAs relative to Rplp0.
Means ⫾ S.D. for n ⫽ 3. *, p ⬍ 0.05 for FSK versus DMSO. B, D, and F, representative Western blot analysis of cytosolic and non-cytosolic fractions for cytosolic (HSP90 and TUB) and nuclear (NPM) markers for experiments in untransfected (B), NXF3-GFP-transfected (D), and NXF1-GFP-transfected (F) cells.

NXF3 alters subcellular distribution of snoRNAs encoded
within the Rpl13a locus. Furthermore, we show that NXF3
associates with many box C/D and box H/ACA snoRNAs and
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regulates distribution of these small non-coding RNAs as a
class. Our data are most consistent with a model in which snoRNAs cycle between the nucleus and cytoplasm and NXF3 efficiently imports snoRNAs from the cytoplasm to the nucleus, a
function that helps to maintain low levels of snoRNAs in the
cytoplasm under basal conditions (Fig. 9). Furthermore, we
show that regulation of snoRNA distribution by FSK requires
NXF3.
NXF family members have been identified based on sequence
similarity and domain architecture that for most includes an
amino-terminal containing RNA-binding protein interaction
domain, a p15/NXT-heterodimerization domain, and a carboxyl-terminal domain involved in nuclear pore binding (25,
26). NXF1, NXF2, NXF3, and NXF5 have been shown to function in nuclear export of mRNAs, whereas NXF7 has been proposed to function in the cytoplasmic trafficking of mRNAs (15,
27–31). NXF3, which lacks carboxyl-terminal domains that
function in nuclear export and nucleoporin binding, has a
CRM1-dependent nuclear export sequence that allows it to
partner with this transport receptor for its mRNA export function (15). Our study provides evidence that NXF3, but not
NXF1, is also involved in transporting snoRNA cargos, expanding the functional repertoire of NXF proteins. Moreover, our
data support a model in which NXF3 has a role in returning
snoRNAs to the nucleus. Functional domains of NXF3 required
for nuclear export of mRNA have been characterized (15, 26).
However, nuclear localization sequences can be highly variable,
and examination of the NXF3 sequence did not reveal motifs
predicted with high likelihood to function in nuclear import,
raising the possibility that NXF3 could function in a complex
with other proteins. Our data provide evidence of a role for
NXF3 in snoRNA transport. However, interaction of NXF3
with snoRNAs could be direct or indirect. In contrast to other
NXF family members, RNA-binding domains of NXF3 are pre-
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Figure 5. Overexpression of NXF3, but not NXF1, alters Rpl13a snoRNA localization in fibroblasts. NIH3T3 fibroblasts were transfected with control
plasmid (GFP) or plasmids encoding NXF3-GFP or NXF1-GFP. A, flow cytometric analysis of transfected cells. n ⫽ 3. B, RT-qPCR of cytosolic Rpl13a snoRNAs for
n ⫽ 3. C, representative Western blot analysis of cytosolic and non-cytosolic fractions for cytosolic (HSP90 and TUB) and nuclear (NPM) markers. Means ⫾ S.D.
*, p ⬍ 0.05 for NXF3 knockdown versus control.

NXF3 regulates localization of snoRNAs

Figure 8. Forskolin effect on snoRNA localization is dependent on NXF3. H9c2 cardiomyoblasts were transfected with scrambled siRNA (ctrl) or two
independent siRNAs targeting NXF3 or siRNA targeting NXF1 and subsequently treated for 1 h with 10 M FSK or vehicle (DMSO). A, RT-qPCR quantification of
total NXF3 and NXF1 relative to Rplp0. B, RT-qPCR quantification of cytosolic Rpl13a snoRNAs relative to Rplp0. Means ⫾ S.D. for n ⫽ 3. *, p ⬍ 0.05 for FSK versus
DMSO.

dicted but have not been functionally confirmed (32). In future
studies, experimental delineation of RNA-binding residues in
NXF3 will facilitate structure–function studies to determine

whether this protein interacts directly with snoRNAs. In addition, future development of an in vitro nuclear transport assay
for snoRNAs will help to test our model.
J. Biol. Chem. (2017) 292(49) 20228 –20239
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Figure 7. Forskolin increases NXF3-GFP-snoRNA association. A and B, NIH3T3 fibroblasts were transfected with plasmid encoding NXF3-GFP (A) or NXF1GFP (B). Following treatment with FSK or vehicle (DMSO) for 1 h, Rpl13a snoRNAs immunoprecipitated with ␣-GFP were quantified by qPCR. C and D,
representative immunofluorescence micrographs of NXF3-GFP-transfected (C) or NXF1-GFP-transfected (D) cells following 1 h of treatment with FSK or vehicle
(DMSO). Graphs report the relative nuclear localization quantified from n ⫽ 3 independent experiments. Scale bar, 50 M. Means ⫾ S.D. for n ⫽ 3. *, p ⬍ 0.05 for
FSK versus DMSO.

NXF3 regulates localization of snoRNAs

Following transcription, snoRNAs that are processed from
the introns of pre-mRNA or that are generated from independently transcribed units first move to Cajal bodies, where they
assemble in to mature snoRNPs, and subsequently to the nucleolus, where they encounter nascent rRNA substrates. PHAX, a
known adaptor for RNA export, is required for movement
to the Cajal body, and CRM1, a nuclear export receptor, is
required for movement to the nucleolus (33). A growing body of
evidence indicates that snoRNAs traffic to the cytoplasm and
extracellular space (8, 10 –13, 34). Whether snoRNAs undergo
processing in the cytoplasm analogous to snRNAs, function
outside the nucleus, or are secreted in a regulated fashion
remains to be determined. Nonetheless, cells maintain a gradient of snoRNAs such that the vast majority of endogenously
expressed snoRNAs remain localized within the nucleus, and
when exogenous snoRNAs are introduced into the cytoplasm,
they are trafficked into the nucleus through the nuclear pore
complex (14, 35). To date, PHAX and Snurportin 1 have been
shown to function in nucleocytoplasmic trafficking of U8, an
independently transcribed, capped box C/D snoRNA (11), but
it is not known whether these proteins regulate the cytosolic
trafficking of other snoRNAs. Our study provides the first demonstration of a transport protein that regulates cytoplasmic
localization of snoRNAs as a class, including both box C/D and
box H/ACA species, and it is likely functioning to return
cytoplasmic snoRNAs to the nucleus. Inhibition of CRM1
function with leptomycin B decreased, rather than increased,
cytosolic snoRNA abundance,3 suggesting that in contrast to
the mRNA export function of NXF3, NXF3-mediated return of
snoRNAs to the nucleus may be independent of this transport
co-receptor.
Transport of RNAs between the nucleus and cytoplasm is a
highly regulated process, and our studies provide new evidence
that FSK regulates the association of snoRNAs and the transport protein, NXF3, as well as the trafficking of both snoRNAs
and NXF3. Although it is possible that FSK-induced translocation of NXF3 leads to increased association with snoRNAs that
3

M. W. Li, and J. E. Schaffer, unpublished data.
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Experimental procedures
Materials
Digitonin, FSK, phenylmethanesulfonyl fluoride (PMSF),
and dimethyl sulfoxide (DMSO) were from Sigma. Protein A
Dynabeads and TURBO DNase were from Thermo Fisher
Scientific. Doxorubicin (DOX) was from Cayman Chemical.
TRIzol LS and SUPERase-IN RNase inhibitor was from Life
Technologies, Inc. DTT was from Calbiochem, and ␤-mercaptoethanol was from Sigma. Laemmli Sample Buffer was
from Bio-Rad.
Plasmids
The NXF3 cDNA was obtained from the Sun lab (42) and
cloned into pEGFP-C1 (Clontech) at BamHI and SalI sites. The
full-length cDNA for mouse NXF1 was obtained by PCR from
the total RNA of NIH3T3 mouse fibroblasts using primers containing BamHI and SalI restrictions sites. NXF1 cDNA was
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Figure 9. Model for NXF3 function in snoRNA localization. snoRNAs cycle
between the nucleus and cytoplasm under homeostatic conditions. NXF3
functions as an importer, efficiently returning snoRNAs to the nucleus to
maintain low snoRNA abundance in the cytoplasm relative to the nucleus.
FSK treatment enhances return of NXF3–snoRNA complexes to the nucleus,
further depleting cytosolic levels of snoRNAs.

are concentrated in the nucleus, our data establish that NXF3 is
required for acute regulation of nuclear snoRNA import by
FSK. FSK is a natural compound that activates cyclic AMP signaling through both PKA-dependent and PKA-independent
mechanisms (36 –39). This could lead to altered post-translational modifications, such as phosphorylation of NXF3 or other
proteins that function in snoRNA transport. Although examination of the NXF3 primary sequence suggests a number of
potential phosphorylation sites, FSK did not change NXF3 phosphorylation, as determined using a panel of ␣-phosphotyrosine,
␣-phosphoserine, and ␣-phosphothreonine antibodies.3 It is
possible that the available antibodies lack the appropriate specificity or that NXF3 is not a direct target of FSK. Future
structure–function and mass spectrometry studies will be necessary to address these possibilities.
Knockdown of NXF3 confers resistance to lipotoxicity, a process dependent on snoRNAs from the Rpl13a locus. These noncoding RNAs accumulate in the cytoplasm early during lipotoxicity (10, 17, 19). Loss of NXF3 also alters distribution of these
snoRNAs at baseline and prevents the acute increase in cytosolic levels with lipotoxicity. The abundance of cytoplasmic
Rpl13a snoRNAs in NXF3-knockdown cells is comparable with
the levels achieved in control cells following acute lipotoxic
exposure. This suggests that the dynamic change in cytosolic
snoRNAs, rather than the absolute cytoplasmic levels of these
non-coding RNAs, is a key contributor to lipotoxic injury.
Recent genetic studies and identification of diseases associated with dysregulation of snoRNAs have expanded the biological repertoire for snoRNAs beyond their well-appreciated
canonical role in modification of nascent rRNAs (9, 40, 41).
Although it is certainly possible that dynamic changes in
snoRNA-directed rRNA modifications contribute to these
intriguing phenotypes, localization of snoRNAs in the cytoplasm also raises the possibility that non-canonical snoRNA
functions are mediated through effects on novel targets outside
the nucleolus. A complete understanding of this new snoRNA
biology requires further dissection of snoRNA trafficking and
its regulation. Our identification of a role for NXF3 in regulated
snoRNA trafficking represents a first step in this important
direction.

NXF3 regulates localization of snoRNAs
cloned into pEGFP-C1 (Clontech) at BamHI and SalI sites.
PCR-derived sequences were confirmed by DNA sequencing.
Cells

shRNA screen
The shRNA screen was performed using Decode Pooled Lentiviral shRNA Libraries by Thermo Fisher Scientific. Immortalized HUVECs were transduced with lentiviral shRNA pools at a
multiplicity of infection of 0.1 and then selected using puromycin. Puromycin-resistant cells were then treated with 500 M
palmitate for 48 h. After removing palmitate, cells were grown
to form colonies in normal media. Colonies were hand-picked
and re-tested for viability following lipotoxic exposure. For this,
cells were plated in a 96-well plate in triplicate (1000 cells per
well) and treated with 500 M palmitate for 24 h. Cells transduced with non-targeting shRNA viral particles (designed to
not target mRNAs in the mammalian genome) were used as
negative control. Colonies with significantly greater viability
than control cells were selected for further analysis. Genomic
DNA was isolated from palmitate-resistant cells, and PCR
was used to amplify barcodes corresponding to specific shRNAs for sequencing. Sequences were compared with the
Decode shRNA libraries or analyzed using BLAST to identify
the knocked down genes.
Subcellular fractionation
For fractionation by detergent extraction, cell pellets were
incubated in digitonin buffer (150 mM NaCl, 50 mM HEPES,
pH 7.4, 100 g/ml digitonin, 5 mM EDTA, and 0.1 unit/l
SUPERase-In RNase inhibitor) for 10 min and centrifuged for
10 min at 2000 ⫻ g to yield a cytoplasmic supernatant and
non-cytoplasmic pellet containing membranes and nuclei (44).

Total RNA was isolated from cytoplasmic or non-cytoplasmic fractions and from immunoprecipitates using TRIzol LS
according to manufacturer’s protocol (Life Technologies, Inc.).
cDNA was synthesized with SuperScript III first-strand synthesis system (Invitrogen) using oligo(dT) priming for mRNAs and
target-specific stem-loop priming snoRNAs (10). qPCR was
performed using PerfeCTa SYBR Green SuperMix (Quantabio). Relative quantitation of target transcript expression was
calculated using the ddCT method using Rplp0 as an endogenous control on an ABI 7500 fast real-time PCR system.
Immunoprecipitation
Cells were sonicated in 50 mM Tris, pH 8.0, 150 mM NaCl, 2
mM EDTA, 0.5% Nonidet P-40 containing 1⫻ cOmplete protease inhibitor mixture (Sigma), 1 mM PMSF, and 0.1 unit/l
RNase inhibitor SUPERase-In. After treatment with 0.3 units/l
TURBO DNase, insoluble material was removed by centrifugation at 20,000 ⫻ g for 10 min at 4 °C. Lysate was incubated with
␣-GFP (2.5 mg/ml) and protein A Dynabeads for 4 h at 4 °C.
Complexes were washed four times with lysis buffer. For Western blot analysis, protein was eluted by incubation in Laemmli
Sample Buffer, and RNA was eluted by incubation in TRIzol LS.
RNA sequencing
Input and immunoprecipitated RNA from three independent experiments was isolated and concentrated using RNA
Clean and Concentrator-5 (Zymo Research). Indexed RNA-sequencing libraries were made using the Illumina TruSeq small
RNA kit. Libraries were amplified with 14 cycles of PCR,
pooled, and separated by PAGE. Products with sizes 30 –375
nucleotides were excised and collected from the gel. Sequencing was performed using an Illumina HiSeq 2500. Demultiplexed data were analyzed using Partek Flow (build version
6.0.17.0305 Copyright ©; 2017 Partek Inc., St. Louis, MO).
Sequences were evaluated for quality and trimmed to
remove adaptor sequence. A custom Linux script was used
to remove murine ribosomal sequences according to the
Illumina iGenome murine genome annotation. Remaining
sequences were aligned to the murine genome (mm9 Refseq
Transcript August 1, 2016, Bowtie for Illumina, default settings), and aligned reads were quantified, normalized, and
annotated. Analysis was limited to genes with ⬎100 aligned
reads. A step-up false discovery rate of 0.05 was considered
significant. Sequence data have been deposited in NCBI’s Gene
Expression Omnibus (accession number GSE106301).
Immunoblots
Protein in total, cytoplasmic, and non-cytoplasmic fractions
was quantified by bicinchoninic assay (Thermo Fisher Scientific), separated by SDS-PAGE, and immunoblotted. Detection
for human nuclear export factor 3 (NXF3; Abcam ab76430,
1:500), GFP (Abcam ab290, 1:5000), heat-shock protein 90
(HSP90; Enzo SPA-846, 1:1000), ␣-tubulin (Sigma T6199,
1:2000), and nucleophosmin (NPM; Abcam ab37659, 1:1500) used
horseradish peroxidase-conjugated secondary antibodies (Jackson
ImmunoResearch) and Western Lightning Plus-ECL (PerkinElmer Life Sciences) using a ChemiDoc Imaging System.
J. Biol. Chem. (2017) 292(49) 20228 –20239
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H9c2 cardiomyoblasts and NIH3T3 fibroblasts were from
American Type Culture Collection. Telomerase-immortalized
HUVECs were a gift from Judah Folkman’s laboratory (Harvard
Medical School) (43), and H9c2 and 3T3 cells were maintained
in Dulbecco’s modified Eagle’s medium (DMEM) with 10%
heat-inactivated fetal bovine serum (H9c2) or 10% calf serum
(NIH3T3). HUVECs were maintained in endothelial cell
growth medium (Lonza). DOX (20 M for 1 h), FSK (10 M for
1 h), H2O2 (1 mM, 4 h), or palmitate (500 M) was added to
media as indicated. Cell viability was determined using
CellTiter-Glo Luminescent Cell Viability Assay (Promega).
Basal cellular ROS was detected by staining cells (100,000 cells
per well of 12-well dishes) with 10 M dihydroethidium (DHE)
(Thermo Fisher Scientific) and detection using a microplate
fluorescence reader (Tecan). ROS after palmitate treatment
was detected by staining cells (200,000 cells per well of 6-cm
dishes) with CellROX Deep Red Reagent (5 M, 30 min)
(Thermo Fisher Scientific) and detection using flow cytometric
analysis on 104 cells/sample. Cells were transfected with plasmid DNA peGFP-1, NXF3-GFP, and NXF1-GFP using Lipofectamine 2000 (Life Technologies, Inc.) and with siRNAs
(Life Technologies, Inc., Silencer Select) using RNAiMax
(Life Technologies, Inc.), according to the manufacturers’
protocols. Flow cytometric analysis of transfected cells
assessed fluorescence on 104 cells/sample.

RNA isolation and quantitative real-time PCR

NXF3 regulates localization of snoRNAs
Immunofluorescence

Statistics
Biochemical results are presented as mean ⫾ S.D. for a minimum of three independent experiments. Statistical significance was assessed by two-tailed unpaired t test. p value ⬍ 0.05
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